APOE and Alzheimer disease: The burden of cardiovascular factors contributes up to 50% of the risk for developing of late-onset AD(51, 63, 64) and while there were no significant differences in FCVRS or blood pressure measures in APOE-ε4 carriers vs. non-carriers, RVI-AD still detected the additional brain effects linked to cardiovascular risks in the carriers.